Literature DB >> 29501453

Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.

Mathias Schwerdt1, Claudia Neumann1, Bianca Schwartbeck1, Stefanie Kampmeier2, Susann Herzog1, Dennis Görlich3, Angelika Dübbers4, Jörg Große-Onnebrink4, Christina Kessler4, Peter Küster5, Holger Schültingkemper5, Janina Treffon1, Georg Peters1, Barbara C Kahl6.   

Abstract

BACKGROUND: Cystic fibrosis (CF) is an autosomal recessive disease associated with chronic airway infections by Staphylococcus aureus as one of the earliest and most prevalent pathogens. We conducted a retrospective study to determine the S. aureus infection status of CF patients treated since 1994 at two certified CF-centres in Münster, Germany, to get insights into the dynamics of S. aureus airway infection and the clinical impact on lung function on a long-term perspective.
MATERIALS AND METHODS: We used data from our microbiological database collected between 1994 and 2016 for patients treated at two centres in Münster, Germany, respectively, to determine the infection status for S. aureus. Furthermore, the resistance to selected antibiotics was determined for all patients' isolates and for 15 patients on a longitudinal basis. In addition, the prevalence of adaptive phenotypes such as small colony variants (SCVs) and mucoid S. aureus was assessed.
RESULTS: For this study, 2867 patient years with respiratory specimens (mean of 9.3 years for every patient, range 1-22 years) were evaluated for 283 CF patients (median age of 7 years at the beginning of the observation period, range 0-57 years, 51% male). 18% of patients were rarely infected by S. aureus (≤24% of observation years), 20% of patients intermittently (25-49%) and 61% persistently (≥50% of observation period). Susceptibility testing for 12969 S. aureus isolates resulted in resistance to methicillin in 9%, trimethoprim/sulfamethoxazole in 10%, levofloxacin in 14%, gentamicin in 20%, erythromycin and/or clindamycin in 30% and penicillin in 80% of all isolates. S. aureus isolates of 15 patients revealed dynamics of resistance with increase, decrease and loss of resistant isolates to the analysed antibiotics during the study period. SCVs were isolated at least once from 42% (n = 118) of patients and mucoid isolates from 2% (n = 7) of patients. In the last study year, 89 patients were infected by S. aureus only, 44 patients by S. aureus and Pseudomonas aeruginosa and 18 by P. aeruginosa only. Patients infected by S. aureus only were younger and had better lung function compared to the other two groups.
CONCLUSIONS: We determined a high percentage of patients with persistent S. aureus infection. During persistence, mostly fluctuation of resistance against various antibiotics was observed in the isolates indicating acquisition and loss of resistance genes by S. aureus. The prevalence of adaptive phenotypes during long-term persistence was high for SCVs (42% of patients), but low for mucoid isolates (2% of patients), which might be underestimated for mucoid phenotypes due to the retrospective study design and the difficulty to detect mucoid isolates in primary cultures. While patients with S. aureus only had better lung function and were younger, no difference was found between the group of P. aeruginosa and S. aureus co-infection and P. aeruginosa only with previous S. aureus infection.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Mucoid phenotypes; Persistence; Resistance; S. aureus; SCVs

Mesh:

Substances:

Year:  2018        PMID: 29501453     DOI: 10.1016/j.ijmm.2018.02.003

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  17 in total

Review 1.  Hyperinflammation and airway surface liquid dehydration in cystic fibrosis: purinergic system as therapeutic target.

Authors:  Thiago Inácio Teixeira do Carmo; Victor Emanuel Miranda Soares; Jonatha Wruck; Fernanda Dos Anjos; Débora Tavares de Resende E Silva; Sarah Franco Vieira de Oliveira Maciel; Margarete Dulce Bagatini
Journal:  Inflamm Res       Date:  2021-04-27       Impact factor: 4.575

Review 2.  The Yin and Yang of Streptococcus Lung Infections in Cystic Fibrosis: a Model for Studying Polymicrobial Interactions.

Authors:  Jessie E Scott; George A O'Toole
Journal:  J Bacteriol       Date:  2019-05-08       Impact factor: 3.490

3.  Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  Laura Camus; Paul Briaud; François Vandenesch; Anne Doléans-Jordheim; Karen Moreau
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.

Authors:  Eryn E Bernardy; Robert A Petit; Vishnu Raghuram; Ashley M Alexander; Timothy D Read; Joanna B Goldberg
Journal:  mBio       Date:  2020-06-23       Impact factor: 7.867

5.  Long-Term Intrahost Evolution of Methicillin Resistant Staphylococcus aureus Among Cystic Fibrosis Patients With Respiratory Carriage.

Authors:  Taj Azarian; Jessica P Ridgway; Zachary Yin; Michael Z David
Journal:  Front Genet       Date:  2019-06-12       Impact factor: 4.772

6.  Help, hinder, hide and harm: what can we learn from the interactions between Pseudomonas aeruginosa and Staphylococcus aureus during respiratory infections?

Authors:  Dominique Hope Limoli; Lucas R Hoffman
Journal:  Thorax       Date:  2019-02-18       Impact factor: 9.139

7.  Sustained Coinfections with Staphylococcus aureus and Pseudomonas aeruginosa in Cystic Fibrosis.

Authors:  Anthony J Fischer; Sachinkumar B Singh; Mason M LaMarche; Lucas J Maakestad; Zoe E Kienenberger; Tahuanty A Peña; David A Stoltz; Dominique H Limoli
Journal:  Am J Respir Crit Care Med       Date:  2021-02-01       Impact factor: 21.405

Review 8.  Curating and comparing 114 strain-specific genome-scale metabolic models of Staphylococcus aureus.

Authors:  Alina Renz; Andreas Dräger
Journal:  NPJ Syst Biol Appl       Date:  2021-06-29

9.  The Virulence Potential of Livestock-Associated Methicillin-Resistant Staphylococcus aureus Cultured from the Airways of Cystic Fibrosis Patients.

Authors:  Janina Treffon; Sarah Ann Fotiadis; Sarah van Alen; Karsten Becker; Barbara C Kahl
Journal:  Toxins (Basel)       Date:  2020-05-30       Impact factor: 4.546

10.  Antibiotic Treatment and Age Are Associated With Staphylococcus aureus Carriage Profiles During Persistence in the Airways of Cystic Fibrosis Patients.

Authors:  Corinna Westphal; Dennis Görlich; Stefanie Kampmeier; Susann Herzog; Nadja Braun; Carina Hitschke; Alexander Mellmann; Georg Peters; Barbara C Kahl
Journal:  Front Microbiol       Date:  2020-02-26       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.